Bioorganic & Medicinal Chemistry Letters | Vol 16, Issue 6, Pages 1451-1758 (15 March 2006) | ScienceDirect.com by Elsevier
BIOORG MED CHEM LETT - Bioorganic and Medicinal Chemistry Letters
Bioorg. Med. Chem. Lett. 2010 Ranjit
Bioorg. Med. Chem. Lett. 2010 Ranjit
Bioorganic & Medicinal Chemistry Letters | Vol 26, Issue 15, Pages 3381-3830 (1 August 2016) | ScienceDirect.com by Elsevier
Bioorganic & Medicinal Chemistry Letters Instructions to Contributors
Bioorganic & Medicinal Chemistry Letters | Vol 28, Issue 14, Pages 2343-2576 (1 August 2018) | ScienceDirect.com by Elsevier
BIOORG MED CHEM LETT - Bioorganic and Medicinal Chemistry Letters
Bioorganic & Medicinal Chemistry template - For Authors
PDF) Design, synthesis, and structure-activity-relationship of phenyl imidazoles as potent Smoothened antagonists
Bioorganic & Medicinal Chemistry Letters期刊最新论文, 化学/材料, - X-MOL
Bioorg. Med. Chem. Lett. 2010 Ranjit
Bioorganic and Medicinal Chemistry Letters impact... | Exaly
Bioorganic & Medicinal Chemistry Letters template - For Authors
Bioorganic & Medicinal Chemistry Letters - The Scripps Research ...
Bioorganic & Medicinal Chemistry Letters
![PDF) Erratum to “Inhibitors of potassium channels KV1.3 and IK-1 as immunosuppressants” [Bioorg. Med. Chem. Lett. 19 (2009) 2299–2304] | Stephan Grissmer - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/42665312/mini_magick20190217-8886-1ojl54i.png?1550420382 "PDF) Erratum to “Inhibitors of potassium channels KV1.3 and IK-1 as immunosuppressants” [Bioorg. Med. Chem. Lett. 19 (2009) 2299–2304] | Stephan Grissmer - Academia.edu")
PDF) Erratum to “Inhibitors of potassium channels KV1.3 and IK-1 as immunosuppressants” [Bioorg. Med. Chem. Lett. 19 (2009) 2299–2304] | Stephan Grissmer - Academia.edu
Bioorganic & Medicinal Chemistry Letters | Vol 30, Issue 22, 15 November 2020 | ScienceDirect.com by Elsevier
Bioorganic & Medicinal Chemistry Letters | Vol 25, Issue 1, Pages 1-152 (1 January 2015) | ScienceDirect.com by Elsevier
![PDF) ChemInform Abstract: Synthesis and in vitro and in vivo Anticancer Activity of Novel 3-Methyl-5H-isoxazolo[5′,4′:5,6]pyrido[2,3-b]indoles.](https://i1.rgstatic.net/publication/231860956_ChemInform_Abstract_Synthesis_and_in_vitro_and_in_vivo_Anticancer_Activity_of_Novel_3-Methyl-5H-isoxazolo5'4'56pyrido23-bindoles/links/5afbe176aca272e7302c496c/largepreview.png "PDF) ChemInform Abstract: Synthesis and in vitro and in vivo Anticancer Activity of Novel 3-Methyl-5H-isoxazolo[5′,4′:5,6]pyrido[2,3-b]indoles.")
PDF) ChemInform Abstract: Synthesis and in vitro and in vivo Anticancer Activity of Novel 3-Methyl-5H-isoxazolo[5′,4′:5,6]pyrido[2,3-b]indoles.
Bioorganic & Medicinal Chemistry Letters | Vol 21, Issue 21, Pages 6207-6614 (1 November 2011) | ScienceDirect.com by Elsevier
Figure 3, Summary of second generation small molecule 3CLpro inhibitors, some containing reactive warhead groups and known to have a covalent mode of action - Probe Reports from the NIH Molecular Libraries
What does Bioorg Med Chem Lett mean? - Definition of Bioorg Med Chem Lett - Bioorg Med Chem Lett stands for Bioorganic and Medicinal Chemistry Letters. By AcronymsAndSlang.com
Magic Chloro-SI
Bioorganic & Medicinal Chemistry Letters | Vol 25, Issue 11, Pages 2251-2452 (1 June 2015) | ScienceDirect.com by Elsevier
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry
